Laser treatment for bothersome eye floaters
Part of Eyes & vision clinical trials.
This trial tests a special laser (YAG laser) to break up annoying eye floaters. It's for people whose floaters have been bothering them for at least 3 months and come from being nearsighted or from a normal aging change in the eye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had floaters for at least 3 months
- Your floaters are from being nearsighted or from a natural aging change (posterior vitreous detachment)
- You have not had YAG laser or surgery for floaters before
- No recent sudden floaters or flashes (within the past 3 months)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a different pattern of laser treatment for people with diabetic eye disease (proliferative diabetic retinopathy) that has started growing abnormal blood vessels. The goal is to see if this pattern works well or better than the standard approach.
This study tests a combination of standard eye injections and laser treatment for wet age-related macular degeneration, a condition where abnormal blood vessels leak fluid and harm vision. It aims to see if this combined approach is safe and effective, potentially reducing the number of injections needed.
This study tests whether a micropulsed laser can reduce swelling in the macula (central vision area) in people with inherited retinal diseases. It may help improve or stabilize vision-related swelling seen on detailed eye scans.
This trial tests a laser procedure called DSLT to lower eye pressure in people with pigmentary glaucoma. It may offer a treatment option for those who have not had prior glaucoma surgeries.
This trial studies a mild (“subthreshold”) laser treatment for reticular pseudodrusen (RPD) caused by age-related macular degeneration (AMD). If you qualify, the goal is to see whether the laser helps preserve or improve vision by targeting these specific eye changes.
This trial tests if a targeted laser treatment guided by a special eye scan can slow the progression of blocked blood vessels in the retina for people with diabetes-related eye disease. It may help preserve vision by treating damaged areas before they worsen.
Hear when a new Posterior Vitreous Detachment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.